Kiniksa Pharmaceuticals (KNSA) Stock Price, Quote, News & History | Benzinga

SPY777.79−0.10%QQQ746.05−0.70%BTC/USD82,510.38−1.40%DIA518.00+0.37%GLD382.07−0.65%TLT78.00+0.02%

Kiniksa Pharmaceuticals International PLC (KNSA) Stock Price, Quote, News & History

KNSANASDAQ

Trade with Public

Trade with Public

$79.70

-0.08-0.1%

Last update: Oct 12, 1:16 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$80.00

Close

-

Volume / Avg.

147.88K / 574.31K

Day Range

$79.70 - $79.70

52 Wk Range

35.20 - 82.94

Market Cap

$6.22B

P/E Ratio

80.59

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

9.45%

Days to Cover

6.41

Recent Kiniksa Pharmaceuticals International, PLC News

Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results

US stocks trade higher, Dow up 1% on Tuesday. Boeing gains 5% after reporting Q2 results. Kiniksa Pharma, OPKO Health, Itron, up over 20%.

Avi Kapoor

Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.

Avi Kapoor

CommVault, Kforce, AxoGen And Other Big Stocks Moving Higher On Tuesday

U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimates. Other gainers include Kforce, Omnicell, and AxoGen.

Avi Kapoor

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Month

Oversold stocks in health care sector present buying opportunity. RSI compares stock's strength on up/down days & predicts short-term performance. Top oversold stocks: KNSA (28) NNOX (28.2) RNA (28.4).

Avi Kapoor

Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

184.97M

Investing Cash Flow (TTM)

-239.07M

Financing Cash Flow (TTM)

37.74M

Free Cash Flow (TTM)

182.84M

Capital Expenditure (TTM)

-2.13M

Net Change in Cash (TTM)

-16.36M

Analyst Trends and Forecast

6

Apr

1

Jun

7

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.71B

PE Ratio (TTM)

80.59

PE Ratio (FWD)

62.50

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.77

PB Ratio (TTM)

9.52

Earnings Yield % (TTM)

1.24%

Earnings Yield % (FWD)

1.60%

EV / EBITDA (TTM)

55.94

Price / EBITDA (TTM)

64.06

Price / Free Cash Flow (TTM)

35.75

Book Value / Share

$8.38

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$175.68M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-